Literature DB >> 30458282

PACAP increases Arc/Arg 3.1 expression within the extended amygdala after fear conditioning in rats.

Edward G Meloni1, Karen T Kaye2, Archana Venkataraman2, William A Carlezon2.   

Abstract

The stress-related neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) is implicated in neuromodulation of learning and memory. PACAP can alter synaptic plasticity and has direct actions on neurons in the amygdala and hippocampus that could contribute to its acute and persistent effects on the consolidation and expression of conditioned fear. We recently demonstrated that intracerebroventricular (ICV) infusion of PACAP prior to fear conditioning (FC) results in initial amnestic-like effects followed by hyper-expression of conditioned freezing with repeated testing, and analyses of immediate-early gene c-Fos expression suggested that the central nucleus of the amygdala (CeA), but not the lateral/basolateral amygdala (LA/BLA) or hippocampus, are involved in these PACAP effects. Here, we extend that work by examining the expression of the synaptic plasticity marker activity-regulated cytoskeleton-associated protein (Arc/Arg 3.1) after PACAP administration and FC. Male Sprague-Dawley rats were implanted with cannula for ICV infusion of PACAP-38 (1.5 µg) or vehicle followed by FC and tests for conditioned freezing. One hour after FC, Arc protein expression was significantly elevated in the CeA and bed nucleus of the stria terminalis (BNST), interconnected structures that are key elements of the extended amygdala, in rats that received the combination of PACAP + FC. In contrast, Arc expression within the subdivisions of the hippocampus, or the LA/BLA, were unchanged. A subpopulation of Arc-positive cells in both the CeA and BNST also express PKCdelta, an intracellular marker that has been used to identify microcircuits that gate conditioned fear in the CeA. Consistent with our previous findings, on the following day conditioned freezing behavior was reduced in rats that had been given the combination of PACAP + FC-an amnestic-like effect-and Arc expression levels had returned to baseline. Given the established role of Arc in modifying synaptic plasticity and memory formation, our findings suggest that PACAP-induced overexpression of Arc following fear conditioning may disrupt neuroplastic changes within populations of CeA and BNST neurons normally responsible for encoding fear-related cues that, in this case, results in altered fear memory consolidation. Hence, PACAP systems may represent an axis on which stress and experience-driven neurotransmission converge to alter emotional memory, and mediate pathologies that are characteristic of psychiatric illnesses such as post-traumatic stress disorder.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amygdala; Arc; BNST; Fear conditioning; PACAP; PKCdelta

Mesh:

Substances:

Year:  2018        PMID: 30458282      PMCID: PMC6494622          DOI: 10.1016/j.nlm.2018.11.011

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  86 in total

1.  Rat central amygdaloid nucleus projections to the bed nucleus of the stria terminalis.

Authors:  N Sun; L Roberts; M D Cassell
Journal:  Brain Res Bull       Date:  1991-11       Impact factor: 4.077

2.  Preview. Angelman syndrome: finding the lost arc.

Authors:  Hwan-Ching Tai; Erin M Schuman
Journal:  Cell       Date:  2010-03-05       Impact factor: 41.582

3.  Neuronal ensembles in amygdala, hippocampus, and prefrontal cortex track differential components of contextual fear.

Authors:  Moriel Zelikowsky; Sarah Hersman; Monica K Chawla; Carol A Barnes; Michael S Fanselow
Journal:  J Neurosci       Date:  2014-06-18       Impact factor: 6.167

4.  Pituitary adenylate cyclase-activating polypeptide induces postsynaptically expressed potentiation in the intra-amygdala circuit.

Authors:  Jun-Hyeong Cho; Ko Zushida; Gleb P Shumyatsky; William A Carlezon; Edward G Meloni; Vadim Y Bolshakov
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

5.  Depression-prone mice with reduced glucocorticoid receptor expression display an altered stress-dependent regulation of brain-derived neurotrophic factor and activity-regulated cytoskeleton-associated protein.

Authors:  R Molteni; F Calabrese; S Chourbaji; C Brandwein; G Racagni; P Gass; M A Riva
Journal:  J Psychopharmacol       Date:  2008-12-12       Impact factor: 4.153

6.  Opposing effects by pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide on hippocampal synaptic transmission.

Authors:  Lucia Ciranna; Sebastiano Cavallaro
Journal:  Exp Neurol       Date:  2003-12       Impact factor: 5.330

7.  Pituitary adenylate cyclase-activating polypeptide (PACAP) in the central nucleus of the amygdala induces anxiety via melanocortin receptors.

Authors:  Attilio Iemolo; Mariel Seiglie; Angelo Blasio; Pietro Cottone; Valentina Sabino
Journal:  Psychopharmacology (Berl)       Date:  2016-07-04       Impact factor: 4.530

Review 8.  Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.

Authors:  David Vaudry; Anthony Falluel-Morel; Steve Bourgault; Magali Basille; Delphine Burel; Olivier Wurtz; Alain Fournier; Billy K C Chow; Hitoshi Hashimoto; Ludovic Galas; Hubert Vaudry
Journal:  Pharmacol Rev       Date:  2009-09       Impact factor: 25.468

9.  Arc in the nucleus regulates PML-dependent GluA1 transcription and homeostatic plasticity.

Authors:  Erica Korb; Carol L Wilkinson; Ryan N Delgado; Kathryn L Lovero; Steven Finkbeiner
Journal:  Nat Neurosci       Date:  2013-06-09       Impact factor: 24.884

10.  Microinfusion of pituitary adenylate cyclase-activating polypeptide into the central nucleus of amygdala of the rat produces a shift from an active to passive mode of coping in the shock-probe fear/defensive burying test.

Authors:  Gabor Legradi; Mahasweta Das; Brian Giunta; Khemraj Hirani; E Alice Mitchell; David M Diamond
Journal:  Neural Plast       Date:  2007       Impact factor: 3.599

View more
  8 in total

Review 1.  Danger and distress: Parabrachial-extended amygdala circuits.

Authors:  A A Jaramillo; J A Brown; D G Winder
Journal:  Neuropharmacology       Date:  2021-08-27       Impact factor: 5.273

Review 2.  Pituitary Adenylate Cyclase Activating Peptide and Post-traumatic Stress Disorder: From Bench to Bedside.

Authors:  Manessa Riser; Seth Davin Norrholm
Journal:  Front Psychiatry       Date:  2022-07-05       Impact factor: 5.435

3.  Extended amygdala circuits are differentially activated by context fear conditioning in male and female rats.

Authors:  Louise Urien; Nicole Stein; Abigail Ryckman; Lindsey Bell; Elizabeth P Bauer
Journal:  Neurobiol Learn Mem       Date:  2021-02-11       Impact factor: 2.877

Review 4.  PACAP orchestration of stress-related responses in neural circuits.

Authors:  Melissa N Boucher; Victor May; Karen M Braas; Sayamwong E Hammack
Journal:  Peptides       Date:  2021-04-15       Impact factor: 3.867

5.  The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus.

Authors:  Gregory C Johnson; Rodney Parsons; Victor May; Sayamwong E Hammack
Journal:  Front Cell Neurosci       Date:  2020-04-30       Impact factor: 5.505

6.  Pituitary adenylate cyclase-activating polypeptide (PACAP) modulates dependence-induced alcohol drinking and anxiety-like behavior in male rats.

Authors:  Valentina Sabino; Pietro Cottone; Antonio Ferragud; Clara Velazquez-Sanchez; Margaret A Minnig
Journal:  Neuropsychopharmacology       Date:  2020-11-16       Impact factor: 7.853

Review 7.  Pituitary Adenylate Cyclase-Activating Polypeptide in Learning and Memory.

Authors:  Marieke R Gilmartin; Nicole C Ferrara
Journal:  Front Cell Neurosci       Date:  2021-06-22       Impact factor: 6.147

Review 8.  Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.

Authors:  Viktoria Denes; Peter Geck; Adrienn Mester; Robert Gabriel
Journal:  J Clin Med       Date:  2019-09-18       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.